Julie Rubinstein sold $989K of Adaptive Biotechnologies (ADPT)

Executed Apr 6, disclosed Apr 8, 2 days later.

Value, as filed

$989K

68,961 sh across 3 lots

Executed

Apr 6

the trade date, as filed

Disclosed

Apr 8

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Julie Rubinstein President and COO profile →

Julie Rubinstein (President and COO) filed 14 Form 4 reports in the trailing twelve months (0 purchases, 14 sales), most often in Adaptive Biotechnologies Corporation (ADPT). The largest single filing was $2.3M of ADPT (174,303 sh across 4 lots, as filed), executed Mar 11.

The name

ADPT

Adaptive Biotechnologies Corporation ADPT · Healthcare · 69 filings in 24 months ticker →

Healthcare · Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of v…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Julie Rubinstein in ADPT

ADPTSALE Adaptive Biotechnologies Corporation $271K
19,037 sh × $14.23
Exec Apr 27
Filed Apr 29 · 5:30 PM ET ADPTSALE Adaptive Biotechnologies Corporation $798K
57,180 sh across 3 lots
Exec Apr 22
Filed Apr 24 · 5:30 PM ET ADPTSALE Adaptive Biotechnologies Corporation $1.0M
69,061 sh across 3 lots
Exec Apr 17
Filed Apr 21 · 5:30 PM ET ADPTSALE Adaptive Biotechnologies Corporation $826K
57,180 sh across 3 lots
Exec Apr 14
Filed Apr 16 · 5:30 PM ET ADPTSALE Adaptive Biotechnologies Corporation $675K
51,342 sh across 3 lots
Exec Apr 9
Filed Apr 13 · 5:30 PM ET ADPTSALE Adaptive Biotechnologies Corporation $554K
38,120 sh across 2 lots
Exec Apr 1
Filed Apr 2 · 5:30 PM ET ADPTSALE Adaptive Biotechnologies Corporation $717K
54,442 sh across 3 lots
Exec Mar 27
Filed Mar 31 · 5:30 PM ET ADPTSALE Adaptive Biotechnologies Corporation $802K
57,180 sh across 3 lots
Exec Mar 24
Filed Mar 26 · 5:30 PM ET